Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Pyrazinamide→

Pyrazinamide Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
98-96-4
Molecular formula
C5H5N3O
Molecular weight
123.11 g/mol
Drug class
Antitubercular agentNicotinamide analogue
Mechanism of action
A prodrug converted by Mycobacterium tuberculosis pyrazinamidase/nicotinamidase to pyrazinoic acid. It is preferentially active under acidic conditions; the precise antibacterial mechanism remains incompletely defined.
Indications / reported uses
  • Initial treatment of active tuberculosis in combination with other antituberculous agents

Sources: DailyMed — Pyrazinamide tablets prescribing information · WHO — Consolidated guidelines on tuberculosis: pyrazinamide pharmacology

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Pyrazinamide Environmental Risk Assessment (ERA) (the Pyrazinamide ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.